Floris J. Pos

6.3k citations

147 papers · 4.3k indexed · 2 hit papers · h-index 35

Impact in

Radiation top 0.1%
- Advanced Radiotherapy Techniques
Pulmonary and Respiratory Medicine top 0.5%
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Radiation Therapy and Dosimetry

Papers in

Radiation 58
- Advanced Radiotherapy Techniques 58
Pulmonary and Respiratory Medicine 102
- Prostate Cancer Diagnosis and Treatment 87
- Prostate Cancer Treatment and Research 58
- Radiation Therapy and Dosimetry 11

Co-authors: Uulke A. van der Heide Wilma D. Heemsbergen Joos V. Lebesque Luca Incrocci Marcel van Herk P. Remeijer Karin Haustermans Linda G.W. Kerkmeijer
Journals: Radiotherapy and Oncology (43 papers)International Journal of Radiation Oncology*Biology*Physics (31 papers)Journal of Clinical Oncology (7 papers)Physics and Imaging in Radiation Oncology (6 papers)Frontiers in Oncology (5 papers)
Partner nations: Netherlands Belgium United Kingdom

In The Last Decade

Floris J. Pos

141 papers receiving 4.2k citations

Hit Papers

align trajectories log scale

Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial 2021 · 299 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Journal of Clinical Oncology
2016 The Lancet Oncology

Peers

Countries citing papers authored by Floris J. Pos

Since Specialization

Citations

This map shows the geographic impact of Floris J. Pos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Floris J. Pos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Floris J. Pos more than expected).

Fields of papers citing papers by Floris J. Pos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Floris J. Pos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Floris J. Pos. The network helps show where Floris J. Pos may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Floris J. Pos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Floris J. Pos Line = papers co-authored together Floris J. Pos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Acute adverse events in the DESTINATION 1 trial: A prospective prostate SBRT dose de-escalation feasibility study Radiotherapy and Oncology ·峰之米田, E. Norris, C. P. Cherry, Joel M. Chick, Olga M. de la Rosa, Alex Dunlop, Željko Marušić, Trina Herbert, Klara Petrović, Albert Liga, Simeon Nill, Zhen-Yu Huang, Floris J. Pos, Nick A. Schuster, 春雄山崎, Yongfa Feng, Emma Soler, A. Amzadeh	2026	0
2	Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: 10-Year Outcomes of the FLAME Trial Journal of Clinical Oncology ·D. А. Akhmadeeva, Cédric Draulans, Floris J. Pos, Linda G.W. Kerkmeijer, Evelyn M. Monninkhof, Robert Jan Smeenk, Martina Kunze-Busch, Hans C.J. de Boer, 景一日野, Karin Haustermans, Uulke A. van der Heide	2025	1
3	External beam radiation therapy versus radical prostatectomy for high-risk prostate cancer: protocol of the RECOVER study BMC Cancer ·Tina K. Halldórsdóttir, Chris H. Bangma, Maarten J. Bijlsma, Alfons C.M. van den Bergh, Lambertus A. Kiemeney, Wietske Kievit, Juliana Oliveira Moreira, Diederik M. Somford, Flóra Jozefíková, Katja K.H. Aben, Igle J. de Jong, Floris J. Pos, 石居昭夫	2025	1
4	2419 Primary endpoint analysis of the phase II DESTINATION-MRL trial for patients with favorable intermediaterisk prostate cancer Radiotherapy and Oncology ·Liwei Wang, Alison Tree, Lisa Wiersema, Nikko Malazarte, Peter de Ruiter, Jan van der Linden, Adam Mitchell, Alex Dunlop, Dylan Y. Breitkreutz, 峰之米田, Floris J. Pos, Tomas Janssen, John Kemp, Uulke A. van der Heide	2025	1
5	Normal tissue complication probability modeling for late rectal bleeding after conventional or hypofractionated radiotherapy for prostate cancer Clinical and Translational Radiation Oncology ·Renata Sarmento Uchoa, Ben Heijmen, Iurii Adam, András Zolnay, Marnix G. Witte, Floris J. Pos, Ben Vanneste, Ludwig J. Dubois, 铁强张, Luca Incrocci, Wilma D. Heemsbergen	2024	1
6	3396: Focal boost SBRT in men with intermediate- and high-risk PCa: 5-year results of the hypo-FLAME trial Radiotherapy and Oncology ·Cédric Draulans, Karin Haustermans, Floris J. Pos, Uulke A. van der Heide, Zack Solomon, Danh Bình An, Hans C.J. de Boer, Robert Jan Smeenk, Martina Kunze-Busch, Evelyn M. Monninkhof, Robin De Roover, Sofie Isebaert, Linda G.W. Kerkmeijer	2024	1
7	Treating Primary Node-Positive Prostate Cancer: A Scoping Review of Available Treatment Options Cancers ·V. S. Mandrusova, Hilda A. de Barros, 杜敬星, André N. Vis, Andries M. Bergman, Floris J. Pos, Reem Shalash Alshammari, Henk G. van der Poel, Wouter V. Vogel, Pim J. van Leeuwen	2023	2
8	Selecting a PRO-CTCAE-based subset for patient-reported symptom monitoring in prostate cancer patients: a modified Delphi procedure ESMO Open ·Erica Feldman, Floris J. Pos, Robert Jan Smeenk, Henk G. van der Poel, Pim van Leeuwen, Jeantine M. de Feijter, Maarten C.C.M. Hulshof, Tom Budiharto, Rosella Hermens, Kelly M. de Ligt, Iris Walraven	2023	7
9	Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: Results From the FLAME Randomized Phase III Trial Journal of Clinical Oncology ·Linda G.W. Kerkmeijer, V. Groen, Floris J. Pos, Karin Haustermans, Evelyn M. Monninkhof, Robert Jan Smeenk, Martina Kunze-Busch, Johannes C.J. de Boer, Jochem van der Voort van Zijp, Marco van Vulpen, Cédric Draulans, Laura Van den Bergh, Sofie Isebaert, Uulke A. van der Heide Hit paper breakdown →	2021	299
10	Anorectal dose–effect relations for late gastrointestinal toxicity following external beam radiotherapy for prostate cancer in the FLAME trial Radiotherapy and Oncology ·V. Groen, Nicolaas P. A. Zuithoff, Caroline Reis Silva, Evelyn M. Monninkhof, Martina Kunze-Busch, Hans C.J. de Boer, Jochem van der Voort van Zyp, Floris J. Pos, Robert Jan Smeenk, Karin Haustermans, Sofie Isebaert, Cédric Draulans, Tom Depuydt, Helena M. Verkooijen, Uulke A. van der Heide, Linda G.W. Kerkmeijer	2021	16
11	Reply to I. R. Vogelius et al Journal of Clinical Oncology ·Linda G.W. Kerkmeijer, Floris J. Pos, Karin Haustermans, Uulke A. van der Heide	2021	4
12	Association between incidental dose outside the prostate and tumor control after modern image-guided radiotherapy Physics and Imaging in Radiation Oncology ·Marnix G. Witte, Floris J. Pos, Luca Incrocci, Wilma D. Heemsbergen	2021	5
13	Radiation with concurrent radiosensitizing capecitabine tablets and single-dose mitomycin-C for muscle-invasive bladder cancer: A convenient alternative to 5-fluorouracil Radiotherapy and Oncology ·Charlotte S. Voskuilen, Anhelina O. Naidovska, James C. Sarver, Laura S. Mertens, Marinus A. Noordzij, Floris J. Pos, Bas W.G. van Rhijn, Michiel S. van der Heijden, Eva E. Schaake	2020	9
14	Primary endpoint analysis of the multicentre phase II hypo-FLAME trial for intermediate and high risk prostate cancer Radiotherapy and Oncology ·Cédric Draulans, Uulke A. van der Heide, Karin Haustermans, Floris J. Pos, Jochem van der Voort van Zyp, Hans de Boer, V. Groen, Evelyn M. Monninkhof, Robert Jan Smeenk, Martina Kunze-Busch, Robin De Roover, Tom Depuydt, Sofie Isebaert, Linda G.W. Kerkmeijer	2020	115
15	Stereotactic body radiation therapy with optional focal lesion ablative microboost in prostate cancer: Topical review and multicenter consensus Radiotherapy and Oncology ·Cédric Draulans, Robin De Roover, Uulke A. van der Heide, Karin Haustermans, Floris J. Pos, Robert Jan Smeenk, Hans de Boer, Tom Depuydt, Martina Kunze-Busch, Sofie Isebaert, Linda G.W. Kerkmeijer	2019	25
16	Superior efficacy of neoadjuvant chemotherapy and radical cystectomy in cT3‐4aN0M0 compared to cT2N0M0 bladder cancer International Journal of Cancer ·Sunwen Ji, Charlotte S. Voskuilen, 平川翔太, Laura S. Mertens, Simon Horenblas, Richard P. Meijer, Joost L. Boormans, Katja K.H. Aben, Michiel S. van der Heijden, Floris J. Pos, Rianne de Wit, Laurens V. Beerepoot, Rob H.A. Verhoeven, Bas W.G. van Rhijn	2018	22
17	Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial The Lancet Oncology ·Luca Incrocci, Ruud C. Wortel, Wendimagegn Alemayehu, Shafak Aluwini, Erik C. Schimmel, Augustinus D. G. Krol, Peter-Paul van der Toorn, Pushkar Kawale, Wilma D. Heemsbergen, Ben Heijmen, Floris J. Pos Hit paper breakdown →	2016	329
18	Sentinel Lymph Node Dissection to Select Clinically Node-negative Prostate Cancer Patients for Pelvic Radiation Therapy: Effect on Biochemical Recurrence and Systemic Progression International Journal of Radiation OncologyBiologyPhysics ·Nikolaos Grivas, Esther Wit, Floris J. Pos, Jeroen de Jong, Erik Vegt, Axel Bex, Kees Hendricksen, Simon Horenblas, Gijs H. KleinJan, Bas van Rhijn, Henk G. van der Poel	2016	15
19	Fusion of planning CT and cystoscopy images for bladder tumor delineation: A feasibility study Medical Physics ·Caitlin C. Jacquot, Floris J. Pos, A. Betgen, Axel Bex, Maarten C.C.M. Hulshof, P. Remeijer, Marcel van Herk	2013	4
20	Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer International Journal of Radiation OncologyBiologyPhysics ·Floris J. Pos, Simon Horenblas, Joos V. Lebesque, L. Moonen, Christoph Schneider, Peter Sminia, Harry Bartelink	2004	17

About Floris J. Pos

Floris J. Pos is a scholar working on Radiation, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Hepatology and Urology, having authored 147 papers that have together received 4.3k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (87 papers), Advanced Radiotherapy Techniques (58 papers), Prostate Cancer Treatment and Research (58 papers), Bladder and Urothelial Cancer Treatments (23 papers), MRI in cancer diagnosis (16 papers), Radiomics and Machine Learning in Medical Imaging (15 papers), Medical Imaging Techniques and Applications (12 papers) and Radiation Therapy and Dosimetry (11 papers). The work is most often cited by research in Radiation (2.3k citations), Pulmonary and Respiratory Medicine (2.9k citations), Radiology, Nuclear Medicine and Imaging (1.5k citations), Urology (264 citations) and Hepatology (176 citations). Floris J. Pos has collaborated with scholars based in Netherlands, Belgium and United Kingdom. Frequent co-authors include Uulke A. van der Heide, Wilma D. Heemsbergen, Joos V. Lebesque, Luca Incrocci, Marcel van Herk, P. Remeijer, Karin Haustermans, Linda G.W. Kerkmeijer, Shafak Aluwini and Ruud C. Wortel. Their work appears in journals such as Radiotherapy and Oncology, International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Physics and Imaging in Radiation Oncology and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact